Skip to main content
. Author manuscript; available in PMC: 2012 Jul 18.
Published in final edited form as: J Neuroendocrinol. 2012 Jul;24(7):1012–1029. doi: 10.1111/j.1365-2826.2012.02311.x

Table 2.

Results of the Elevated Plus-Maze Test and Locomotor Activity Test in Experiment 1A.

Experiment 1A Vehicle
(n = 9)
10 mg / kg
WAY 267,464
(n = 6)
100 mg / kg
WAY 267,464
(n = 7)
Elevated plus-maze
 Open arm time (%) 16.6 ± 2.2 14.6 ± 2.4 13.7 ± 1.5
 Open arm entries (n) 11.4 ± 1.1 7.8 ± 1.5 8.4 ± 1.2
 Total arm entries (n) 17.2 ± 1.7 13.0 ± 2.4 13.1 ± 1.5
 Risk assessment (s) 21.2 ± 2.2 35.2 ± 10.8 21.0 ± 1.9
Locomotor activity test
 Distance travelled (m) 35.6 ± 5.2 29.2 ± 4.3 15.2 ± 1.7a,b
a

Significantly different from vehicle;

b

Significantly different from 10 mg / kg WAY 267,464. Data are represented as the mean ± SEM.